Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Off-Label Use of AVASTIN (BEVACIZUMAB)Intravitreal Injection For the Treatment of Serosanguinous Maculopathy

NCT00344617 is registered in ClinicalTrials.gov with Singapore National Eye Centre as lead sponsor.

NCT NCT00344617
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00344617 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Off-Label Use of AVASTIN (BEVACIZUMAB)Intravitreal Injection For the Treatment of Serosanguinous Maculopathy
Lead sponsor
Singapore National Eye Centre
Phase
Phase 3
Overall status
Unknown status
Start date
June 30, 2006
Completion date
May 31, 2008
Enrollment
50 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

choroidal neovascularisation, polypoidal choroidal vasculopathy